NEW YORK, July 4, 2014 /PRNewswire/ -- Faruqi & Faruqi,
LLP, a leading national securities law firm, is investigating
potential securities fraud at Northwest Biotherapeutics, Inc.
("Northwest" or the "Company") (NASDAQ: NWBO).
On June 19, 2014,
TheStreet.com published an article stating that "[t]he
prestigious MD Anderson Cancer Center issued a stern rebuke to
Northwest Biotherapeutics for making promotional, unjustified
claims about results from an ongoing clinical trial of an
experimental cancer vaccine known as DCVax-Direct… MD Anderson is
running the DCVax-Direct phase I/II clinical trial with funding
from Northwest Bio[therapeutics], which makes the hospital's
criticism of the company's tactics even more significant."
Following this news, the price of Northwest shares declined by
$1.79 per share, or over 19%, to
close on June 19, 2014 at
$7.18 per share.
Request more information now by clicking here:
www.faruqilaw.com/NWBO. There is no cost or obligation to
you.
Take Action
If you invested in Northwest stock or options prior to
June 19, 2014 and would like to
discuss your legal rights, visit www.faruqilaw.com/NWBO. You
can also contact us by calling Richard
Gonnello toll free at 877-247-4292 or at 212-983-9330 or by
sending an e-mail to rgonnello@faruqilaw.com. Faruqi &
Faruqi, LLP also encourages anyone with information regarding
Northwest's conduct to contact the firm, including whistleblowers,
former employees, shareholders and others.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The
firm is focused on providing exemplary legal services in complex
litigation in the areas of securities, shareholder, antitrust and
consumer litigation, throughout all phases of litigation. The
firm has an experienced trial team which has achieved significant
victories on behalf of the firm's clients. To keep track of the
latest securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or
predict a similar outcome with respect to any future matter.
We welcome the opportunity to discuss your particular case.
All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello,
Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
Logo -
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
SOURCE Faruqi & Faruqi, LLP